Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Derma-2

K-Number: K253911 · 2026-05-20

Decision Date2026-05-20
Product CodeLHQ
Advisory CommitteeOB
DecisionSubstantially Equivalent

Device Summary

Derma-2 is the device name listed in this FDA 510(k) record. The listed applicant is Neko Health AB. It received FDA 510(k) clearance on 2026-05-20 under 510(k) number K253911. The device is classified under product code LHQ. It was reviewed by the OB advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Derma-2?

Derma-2 is a medical device that received FDA 510(k) clearance on 2026-05-20. The listed applicant is Neko Health AB. The 510(k) number is K253911.

When did Derma-2 receive FDA 510(k) clearance?

Derma-2 received FDA 510(k) clearance on 2026-05-20, under 510(k) number K253911.

Who is the listed applicant for Derma-2?

The FDA 510(k) record lists Neko Health AB as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Derma-2?

The FDA product code for Derma-2 is LHQ.

Other records listing Neko Health AB as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: LHQ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.